Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 505 across all filing types
Latest filing 2025-08-08 Regulatory Filings
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
[기재정정]투자판단관련주요경영사항 (OliPass PNA 플랫폼 기술 기반 희귀질환 치료제 및 면역항암제 관련 치료제 개발을 위한 Vanda 제약과 신약 공동연구개발 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean company OliPass regarding a 'Material Matter Related to Investment Judgment' (투자판단 관련 주요경영사항). It specifically details an amendment to a joint research and development contract with Vanda Pharmaceuticals, including changes to the contract duration and disclosure of confidential information. Since this is a formal regulatory announcement of a material business event (contract amendment) rather than a financial report, dividend notice, or management change, it falls under the general regulatory filing category.
2025-08-08 Korean
불성실공시법인지정예고 (공시번복 2건)
Regulatory Filings Classification · 100% confidence The document is a formal notice from the Korea Exchange (KRX) regarding the designation of 'Olipass' as an 'Unfaithful Disclosure Corporation' due to the cancellation of capital increase disclosures. This is a regulatory notification concerning compliance and potential penalties (delisting/trading suspension), which falls under the category of regulatory filings or legal/regulatory notices. Since it does not fit into specific categories like M&A, dividends, or financial reports, it is classified as a Regulatory Filing (RNS).
2025-07-23 Korean
기타시장안내 (개선계획서 제출)
Delisting Announcement Classification · 100% confidence The document is a regulatory announcement from the Korea Exchange regarding the submission of an improvement plan by Olipass Co., Ltd. following a listing eligibility review. It details the procedural steps for potential delisting or improvement periods. Since it is a regulatory notice regarding market status and listing procedures rather than a financial report or a specific corporate action like a dividend or director dealing, it falls under the general regulatory filing category.
2025-07-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. This type of filing is a mandatory disclosure for insiders or major shareholders (10% or more) to report changes in their shareholdings, which falls under the category of 'Director's Dealing' (DIRS) as it tracks insider/major shareholder transactions and ownership status.
2025-07-15 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Olipass) regarding a correction (amendment) to a previously filed notice of an Extraordinary General Meeting (EGM). It details the change in the meeting date and provides updated logistical information. Since this is a formal regulatory announcement regarding the scheduling and procedural aspects of a shareholder meeting, it falls under the category of Proxy Solicitation & Information Statement (PSI) as it relates to the formal process of convening shareholders.
2025-07-09 Korean
[기재정정]주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the setting of a record date for a shareholder meeting (임시주주총회). It is a formal notice of a corporate action related to shareholder rights and meeting logistics. Since it does not fit into specific categories like dividend announcements or proxy solicitations, and is a standard regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2025-07-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.